phloretin has been researched along with Colorectal Cancer in 3 studies
Excerpt | Relevance | Reference |
---|
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Kapoor, S | 1 |
Padwad, YS | 1 |
Chang, CK | 1 |
Chiu, PF | 1 |
Yang, HY | 1 |
Juang, YP | 1 |
Lai, YH | 2 |
Lin, TS | 1 |
Hsu, LC | 1 |
Yu, LC | 1 |
Liang, PH | 1 |
Lin, ST | 1 |
Tu, SH | 1 |
Yang, PS | 1 |
Hsu, SP | 1 |
Lee, WH | 1 |
Ho, CT | 1 |
Wu, CH | 1 |
Chen, MY | 1 |
Chen, LC | 1 |
3 other studies available for phloretin and Colorectal Cancer
Article | Year |
---|---|
Phloretin induces G2/M arrest and apoptosis by suppressing the β-catenin signaling pathway in colorectal carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; beta Catenin; Cell Line, Tumor; Cell Proliferation; Colonic Neopla | 2023 |
Targeting Colorectal Cancer with Conjugates of a Glucose Transporter Inhibitor and 5-Fluorouracil.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Disease Model | 2021 |
Apple Polyphenol Phloretin Inhibits Colorectal Cancer Cell Growth via Inhibition of the Type 2 Glucose Transporter and Activation of p53-Mediated Signaling.
Topics: Aged; Animals; Antioxidants; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Colorectal Neoplas | 2016 |